Boston Scientific (NYSE:BSX) has unveiled plans for a €100 million ($118 million) expansion of its operations outside Galway, an Irish economic development agency announced today.
IDA Ireland said the project will create more than 300 jobs in the coming years. The construction project will create more than 40,000 ft2 of carbon-neutral medical device manufacturing space powered by renewable energy at Ballybrit outside Galway.
“This is a welcome investment in the medical technology industry in Galway and the entire region, and it reflects real confidence in the quality and talent of the Irish workforce,” Irish Taoiseach Micheál Martin said in a news release. “Ireland has established itself as a global leader in the sector, with exciting opportunities to produce innovations that improve patient health and quality of life.”
Boston Scientific has had a presence in Galway for nearly 30 years, expanding the site’s capabilities to include advanced product design, R&D and manufacturing. The company exports more than 4 million medical devices from the Galway facility every year, including heart stents and valves, vascular balloons and oesophageal stents.
“This expansion reflects the important contributions of our workforce here in Galway and the strength of the broader business and local community in the west region,” said James Lyons, VP of Operations at Boston Scientific. “In addition to the investment in our physical space, we remain committed to fostering an inclusive workplace where all employees can find opportunities to grow in their careers.”